Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
Clinical Ophthalmology Nov 02, 2017
Torkildsen G, et al. - Herein, a new artificial tear product, Rohto Dry-Aid was investigated for its ability to relieve the signs and symptoms of dry eye disease (DED). Comparable effects were reported by the two products, Rohto Dry-Aid and Systane Ultra, in terms of the signs and symptoms of DED. Although both products were designed to yield long-lasting relief, the Rohto group patients experienced a superior relief from discomfort related to visual tasking activities and daily diaries. This data suggested that the Rohto drops could present a longer duration of symptomatic relief over the course of the day.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries